Sign In
Buy ANIX
$3.42
-0.140 (-3.93%)
At Close: Jul 31, 2026
Brokerages Expect Anixa Biosciences, Inc. (NASDAQ:ANIX) Will Announce Earnings of -$0.09 Per Share
04:36pm, Saturday, 04'th Dec 2021 Dakota Financial News
Brokerages expect Anixa Biosciences, Inc. (NASDAQ:ANIX) to announce earnings per share of ($0.09) for the current fiscal quarter, according to Zacks. Zero analysts have provided estimates for Anixa Biosciences earnings. Anixa Biosciences reported earnings per share of ($0.81) in the same quarter last year, which suggests a positive year-over-year growth rate of 88.9%. The business []
Zacks: Brokerages Expect Anixa Biosciences, Inc. (NASDAQ:ANIX) Will Announce Earnings of -$0.09 Per Share
11:12am, Thursday, 02'nd Dec 2021 Transcript Daily
Wall Street brokerages expect Anixa Biosciences, Inc. (NASDAQ:ANIX) to report earnings of ($0.09) per share for the current quarter, according to Zacks. Zero analysts have made estimates for Anixa Biosciences earnings. Anixa Biosciences reported earnings per share of ($0.81) in the same quarter last year, which would suggest a positive year over year growth rate []
Wealth Alliance Advisory Group LLC Takes Position in Anixa Biosciences, Inc. (NASDAQ:ANIX)
05:16pm, Thursday, 18'th Nov 2021 Dakota Financial News
Wealth Alliance Advisory Group LLC acquired a new position in shares of Anixa Biosciences, Inc. (NASDAQ:ANIX) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 16,413 shares of the companys stock, valued at approximately $78,000. Other institutional investors and hedge []
Anixa Biosciences Announces Notice of Allowance for Additional Patent on its CAR-T Cancer Therapy
08:30am, Friday, 01'st Oct 2021
SAN JOSE, Calif., Oct. 1, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX) ("Anixa"), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, anno
Anixa Biosciences' Ovarian Cancer CAR-T Therapy to be Discussed at Upcoming Emerging Immunotherapeutics for Ovarian Cancer Symposium
08:31am, Tuesday, 14'th Sep 2021
SAN JOSE, Calif., Sept. 14, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced t
Anixa Biosciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
08:30am, Wednesday, 08'th Sep 2021
SAN JOSE, Calif., Sept. 8, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced t
Anixa Biosciences Appoints Dr. Pamela Garzone As Chief Development Officer
08:30am, Tuesday, 07'th Sep 2021
SAN JOSE, Calif., Sept. 7, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced tod
SAN JOSE, Calif., Aug. 30, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced t
Anixa Biosciences' Covid-19 Compounds Expected to be Effective Against the Delta Variant
08:30am, Wednesday, 25'th Aug 2021
SAN JOSE, Calif., Aug. 25, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced to
Anixa Biosciences Congratulates Director, Dr. Arnold Baskies for His Appointment to the WHO's Global Breast Cancer Initiative
08:30am, Monday, 23'rd Aug 2021
SAN JOSE, Calif., Aug. 23, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced t
Anixa Biosciences Announces Issuance of U.S. Patent for Ovarian Cancer Vaccine Technology
08:30am, Wednesday, 18'th Aug 2021
SAN JOSE, Calif., Aug. 18, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced to
ANIX Stock Price: Over 15% Increase Pre-Market Explanation
08:20am, Thursday, 27'th May 2021
The stock price of Anixa Biosciences Inc (NASDAQ: ANIX) increased by over 15% pre-market. This is why it happened.
Anixa Biosciences Announces Support from the National Cancer Institute for Ovarian Cancer Vaccine Developed by Cleveland Clinic
08:30am, Wednesday, 26'th May 2021
SAN JOSE, Calif., May 26, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced tod
Anixa Biosciences and Moffitt Cancer Center Receive Additional Information Request from US FDA for CAR-T IND Application
08:30am, Thursday, 20'th May 2021
SAN JOSE, Calif., May 20, 2021 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced tod
OntoChem Assigns Anixa Covid-19 Drug Discovery Project to MolGenie
08:30am, Friday, 07'th May 2021
HALLE (SAALE), Germany, May 7, 2021 /PRNewswire/ -- OntoChem GmbH, a German Life Science IT company, announced today that it has assigned its drug discovery technologies and assets, including its dru
